Nikang Therapeutics
Wilmington, United States · Founded 2017 · $260.0M raised
- Headquarters
- Wilmington, Delaware
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- nikangtx.com
- Total Funding
- $260.0M
- Last Round
- $200.0M Series CMay 2021
- Rounds
- 3
About
Clinical-stage biotech company developing innovative small molecule oncology drugs.
Summary
Nikang Therapeutics is a Biotech company based in Wilmington, United States, founded in 2017. It has raised $260.0M in total across 3 rounds, most recently a $200.0M Series C round in May 2021. Investors include RTW Investments, Cormorant Asset Management and EcoR1 Capital.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...